Quotient Bioresearch has announced that its state-of-the-art radiochemistry facility in Cardiff is fully operational and that shipments of radiolabelled products have commenced. All staff have now transferred from the former site operated by Amersham Radiolabelling Services to the new facility.
Located close to Cardiff Bay, the facility represents a significant investment by Quotient and follows the company’s acquisition of Amersham Radiolabelling Services from GE Healthcare in June last year. The facility has been named The Old Glassworks, reflecting the origins of the site on which it was built.
The Old Glassworks will produce radiolabelled compounds for its pharmaceutical, biotechnology and agrochemical clients, offering an established bespoke service for the custom synthesis of carbon 14- and tritium-labelled compounds. The facility has been equipped with world-class technology, operating to the highest environmental and safety standards. It houses the largest and most experienced team of radiosynthesis chemists in the world and brings the total number of Quotient employees to over 600.
www.quotientbioresearch.com